Search Results - "Burroughs, K. D."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Dysregulation of IGF-I signaling in uterine leiomyoma by Burroughs, KD, Howe, SR, Okubo, Y, Fuchs-Young, R, LeRoith, D, Walker, CL

    Published in Journal of endocrinology (01-01-2002)
    “…IGF-I expression has been observed in human uterine leiomyomas. To examine whether autocrine IGF-I signaling plays a role in the growth of these tumors, we…”
    Get full text
    Journal Article
  2. 2

    Altered Hormonal Responsiveness of Proliferation and Apoptosis During Myometrial Maturation and the Development of Uterine Leiomyomas in the Rat by BURROUGHS, Kevin D, FUCHS-YOUNG, Robin, DAVIS, Barbara, WALKER, Cheryl L

    Published in Biology of reproduction (01-11-2000)
    “…Uterine leiomyomas are responsive to the ovarian steroids, estrogen and progesterone; however, a mechanistic understanding of the role of these hormones in the…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma by Gamage, S D, Bischoff, E D, Burroughs, K D, Lamph, W W, Gottardis, M M, Walker, C L, Fuchs-Young, R

    “…The conventional treatment of uterine leiomyomas, or fibroids, with gonadotropin-releasing hormone (GnRH) agonists is often associated with serious side…”
    Get more information
    Journal Article
  5. 5

    Regulation of apoptosis in uterine leiomyomata by Burroughs, K D, Kiguchi, K, Howe, S R, Fuchs-Young, R, Trono, D, Barrett, J C, Walker, C

    Published in Endocrinology (Philadelphia) (01-07-1997)
    “…Tumors developing from hormone-dependent tissues, such as the breast and prostate, have been successfully treated in the clinic by methods of hormone ablation,…”
    Get full text
    Journal Article
  6. 6

    Potentiation of oncolytic adenoviral vector efficacy with gutless vectors encoding GMCSF or TRAIL by Burroughs, Kevin D, Kayda, Dawn B, Sakhuja, Kiran, Hudson, Yvette, Jakubczak, John, Bristol, J Andrew, Ennist, David, Hallenbeck, Paul, Kaleko, Michael, Connelly, Sheila

    Published in Cancer gene therapy (01-02-2004)
    “…Oncolytic adenoviral vectors selectively replicate in and lyse human tumor cells, providing a promising means for targeted tumor destruction. However,…”
    Get full text
    Journal Article
  7. 7

    Phase I trial of Seneca Valley Virus (NTX-010), a newly discovered systemically deliverable oncolytic picornavirus, in patients with solid tumors with neuroendocrine features by Rudin, C. M., Lansey, D., Burroughs, K. D., Hales, L. M., Neefe, J. R., Reddy, P. S., Hallenbeck, P. L.

    Published in Journal of clinical oncology (20-06-2007)
    “…Abstract only 18014 Background: NTX-010 is a replication-competent cytolytic picornavirus with selective tropism for cancers with neuroendocrine features…”
    Get full text
    Journal Article
  8. 8

    Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma by Walker, C L, Burroughs, K D, Davis, B, Sowell, K, Everitt, J I, Fuchs-Young, R

    “…Uterine leiomyoma are the most common gynecologic neoplasm and a primary cause of hysterectomy in premenopausal women. Preclinical studies were conducted in…”
    Get more information
    Journal Article
  9. 9

    Phosphatidylinositol 3-Kinase and Mek1/2 Are Necessary for Insulin-Like Growth Factor-I-Induced Vascular Endothelial Growth Factor Synthesis in Prostate Epithelial Cells: A Role for Hypoxia-Inducible Factor-1? by BURROUGHS, Kevin D, OH, Jennifer, BARRETT, J. Carl, DIAUGUSTINE, Richard P

    Published in Molecular cancer research (01-02-2003)
    “…Due to the importance of vascular endothelial growth factor (VEGF) in the neovascularization of solid tumors, a clear understanding of how VEGF is regulated in…”
    Get full text
    Journal Article